- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
A public complaint challenged a Rectogesic press release implying it aided fissure healing. PMCPA ruled the statement inaccurate (Clauses 9.1, 20.2) but…
Shire alerted the PMCPA that a Calcichew-D3 Forte ad (linked to a prior breach campaign) ran in MIMS despite instructions to destroy…
PMCPA case AUTH/3003/12/17 (Director v Clinuvel UK) concerning clinical trial disclosure for Scenesse. Outcome: no breach; matter was outwith the scope of…
A consultant complained to the PMCPA about Takeda’s promotion of vedolizumab. The case was concluded with no breach because the matter was…
PMCPA complaint about clinical trial disclosure for Xiapex. The matter was ruled outwith the scope of the ABPI Code; no breach found…
PMCPA case AUTH/2613/6/13 about a Cerazette discount scheme. The matter was found to be outwith the scope of the ABPI Code (2012)…
MSD’s nurse audit programme was found to be linked to Cozaar promotion via branded training slides and targeting criteria. Breaches of Clauses…
Anonymous consultant alleged pre-licence promotion of Epidiolex at a hospital MDT meeting. Panel had concerns about documentation but found, on balance, it…
A PCT medicines management team member alleged MSD’s Januvia budget impact model was misleading on heart failure and competitor costs. Panel found…
Bayer was held responsible for a sporting celebrity’s favourable comments about Levitra in BBC and Saga online interviews. The Panel ruled this…
GSK disclosed that Avandamet ads ran for ~3 months with outdated prescribing information omitting macular oedema as a rare but serious side…
A journal ad for Arimidex claimed “26% is a very big difference… if you are that 1 in 4”. The Panel ruled…
PMCPA case AUTH/2140/7/08 (Consultant physician v UCB Pharma) about availability of Neupro. The matter was found outwith the scope of the ABPI…
PMCPA case AUTH/2381/1/11 (Director/Merz Pharma v Allergan): complaint alleged breach of undertaking. PMCPA recorded no breach as the matter was outwith the…
Profile used PICO trial summaries (including a competitor study) to support Xadago market access. Panel accepted comparisons were inevitable, but ruled the…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.